gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:bfsLayer
|
5
|
gptkbp:bfsParent
|
gptkb:Zoonotic_Diseases
|
gptkbp:carbonation
|
gptkb:virus
epidemiological studies
pathogenicity
public health impact
genetic sequencing
emerging virus
zoonotic origin
|
gptkbp:caused_by
|
gptkb:MERS-Co_V
|
gptkbp:clinical_trial
|
ongoing
|
gptkbp:distribution
|
gptkb:Europe
gptkb:Middle_East
gptkb:Asia
gptkb:North_America
|
gptkbp:end_of_life
|
approximately 34%
|
gptkbp:first_published
|
gptkb:2012
|
gptkbp:healthcare
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:battle
guidelines for prevention
|
https://www.w3.org/2000/01/rdf-schema#label
|
MERS
|
gptkbp:is_monitored_by
|
contact tracing
reporting systems
active case finding
|
gptkbp:is_protected_by
|
avoid contact with camels
|
gptkbp:is_recognized_by
|
gptkb:Monarch
|
gptkbp:is_vulnerable_to
|
under development
|
gptkbp:related_species
|
gptkb:SARS-Co_V
gptkb:SARS-Co_V-2
|
gptkbp:research_focus
|
vaccine development
treatment options
public health strategies
transmission dynamics
|
gptkbp:reservoir
|
camels
|
gptkbp:responds_to
|
guidelines for healthcare
monitoring cases
|
gptkbp:risk_factor
|
healthcare settings
travel to endemic areas
close contact with infected individuals
working with camels
|
gptkbp:scientific_classification
|
gptkb:World_Health_Organization
|
gptkbp:social_responsibility
|
gptkb:Monarch
gptkb:Qatar
gptkb:Saudi_Arabia
gptkb:United_Arab_Emirates
gptkb:zoo
PCR test
|
gptkbp:symptoms
|
gptkb:healthcare_organization
headache
muscle pain
cough
fever
sore throat
shortness of breath
gastrointestinal symptoms
|
gptkbp:transmission
|
human-to-human
|
gptkbp:treatment
|
supportive care
monoclonal antibodies
no specific antiviral treatment
experimental therapies
convalescent plasma
|